.gif)
Guidance Notes and Best Practice Guides
NICE: Final draft guidance published recently by NICE, confirms its previous positive draft recommendation for naftidrofuryl oxalate as an option to treat people who suffer from intermittent claudication caused by peripheral arterial disease and for whom vasodilator therapy is considered appropriate after taking into account other treatment options.
